Get started
000

DAEHAN NEW PHARM CO., LTD.

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

054670 chart


Full chart

Key stats


Market capitalization
‪99.09 B‬ KRW
Dividend yield (indicated)
1.42%
Price to earnings Ratio (TTM)
10
Basic EPS (TTM)
680 KRW
Net income (FY)
‪12.54 B‬ KRW
Revenue (FY)
‪204.22 B‬ KRW
Shares float
‪8.06 M‬
Beta (1Y)
0.47

Employees


Employees (FY)
377
Change (1Y)
+8 +2.17%
Revenue / Employee (1Y)
‪416.03 K‬ KRW
Net income / Employee (1Y)
‪25.55 K‬ KRW

About DAEHAN NEW PHARM CO., LTD.


Sector
Health Technology
CEO
Won-Seok Lee
Headquarters
Hwaseong-si
Website
dhnp.co.kr
Founded
1984
ISIN
KR7054670005
FIGI
BBG000LKKRJ9
Daehan New Pharm Co., Ltd. engages in the production of pharmaceuticals and animal health goods. It operates through the following business divisions: Pharmaceutical, Animal Health Product, Overseas, and Bio. The Pharmaceutical division provides analgesics anti-inflammatory drugs and antipyretics, antibacterial, antidiabetics, antihistamines, antineoplastics and immunosuppressants, cardiovascular drugs, gatrointestinal drugs, muscle relaxants, antispasmodics, cream, and others. The Animal Health division offers antibacterial, coccidiostats, probiotic, antihelmintics, nutrients, metabolic stimulants, disinfectants, functional supplement feeds, liver tonics, antihelmintics, and others for poultries, cattle, sheep, swine, and fishes. The company was founded on October 20, 1984 and is headquartered in Hwaseong-si, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 054670 is 7,160 KRW — it has decreased by −0.99% in the past 24 hours. Watch DAEHAN NEW PHARM CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange DAEHAN NEW PHARM CO., LTD. stocks are traded under the ticker 054670.
054670 stock has fallen by −0.57% compared to the previous week, the month change is a −13.49% fall, over the last year DAEHAN NEW PHARM CO., LTD. has showed a −19.82% decrease.
054670 reached its all-time high on Sep 2, 2014 with the price of 42,100 KRW, and its all-time low was 790 KRW and was reached on Aug 5, 2004. View more price dynamics on 054670 chart.
See other stocks reaching their highest and lowest prices.
054670 stock is 3.86% volatile and has beta coefficient of 0.47. Track DAEHAN NEW PHARM CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is DAEHAN NEW PHARM CO., LTD. there?
Today DAEHAN NEW PHARM CO., LTD. has the market capitalization of ‪99.09 B‬, it has increased by 2.77% over the last week.
Yes, you can track DAEHAN NEW PHARM CO., LTD. financials in yearly and quarterly reports right on TradingView.
054670 net income for the last quarter is ‪1.97 B‬ KRW, while the quarter before that showed ‪5.60 B‬ KRW of net income which accounts for −64.85% change. Track more DAEHAN NEW PHARM CO., LTD. financial stats to get the full picture.
Yes, 054670 dividends are paid annually. The last dividend per share was 100.00 KRW. As of today, Dividend Yield (TTM)% is 1.42%. Tracking DAEHAN NEW PHARM CO., LTD. dividends might help you take more informed decisions.
DAEHAN NEW PHARM CO., LTD. dividend yield was 1.10% in 2023, and payout ratio reached 11.19%. The year before the numbers were 1.17% and 5.77% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 22, 2024, the company has 377.00 employees. See our rating of the largest employees — is DAEHAN NEW PHARM CO., LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DAEHAN NEW PHARM CO., LTD. EBITDA is ‪19.67 B‬ KRW, and current EBITDA margin is 10.94%. See more stats in DAEHAN NEW PHARM CO., LTD. financial statements.
Like other stocks, 054670 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DAEHAN NEW PHARM CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DAEHAN NEW PHARM CO., LTD. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DAEHAN NEW PHARM CO., LTD. stock shows the strong sell signal. See more of DAEHAN NEW PHARM CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.